Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-027706
Filing Date
2008-12-12
Accepted
2008-12-12 14:57:10
Documents
1
Period of Report
2008-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 10034
  Complete submission text file 0001140361-08-027706.txt   11895
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 ROME ITALY L6 00000
Business Address
CAVAZZA CLAUDIO (Reporting) CIK: 0001164803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 081246390